J Virol. 1994 Jul;68(7):4650-5.

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD.

Source

Aaron Diamond AIDS Research Center, New York University School of Medicine, New York 10016.

Abstract

Virologic and immunologic studies were performed on five patients presenting with primary human immunodeficiency virus type 1 (HIV-1) infection. CD8+ cytotoxic T lymphocyte (CTL) precursors specific for cells expressing antigens of HIV-1 Gag, Pol, and Env were detected at or within 3 weeks of presentation in four of the five patients and were detected in all five patients by 3 to 6 months after presentation. The one patient with an absent initial CTL response had prolonged symptoms, persistent viremia, and low CD4+ T-cell count. Neutralizing antibody activity was absent at the time of presentation in all five patients. These findings suggest that cellular immunity is involved in the initial control of virus replication in primary HIV-1 infection and indicate a role for CTL in protective immunity to HIV-1 in vivo.

PMID:: 8207839; [PubMed - indexed for MEDLINE]
PMCID: PMC236393

Free PMC Article

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

HIV Antibodies

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Related citations

Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients. [AIDS Res Hum Retroviruses. 1997]
Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients.
Legrand E, Pellegrin I, Neau D, Pellegrin JL, Ragnaud JM, Dupon M, Guillemain B, Fleury HJ. AIDS Res Hum Retroviruses. 1997 Nov 1; 13(16):1383-94.
Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection. [J Virol. 1999]
Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.
Hay CM, Ruhl DJ, Basgoz NO, Wilson CC, Billingsley JM, DePasquale MP, D'Aquila RT, Wolinsky SM, Crawford JM, Montefiori DC, et al. J Virol. 1999 Jul; 73(7):5509-19.
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. [J Virol. 1994]
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. J Virol. 1994 Sep; 68(9):6103-10.
Review Cellular immune response to human immunodeficiency virus. [AIDS. 2001]
Review Cellular immune response to human immunodeficiency virus.
Norris PJ, Rosenberg ES. AIDS. 2001 Feb; 15 Suppl 2:S16-21.
Review Anti-HIV adaptive immunity: determinants for viral persistence. [Rev Med Virol. 2008]
Review Anti-HIV adaptive immunity: determinants for viral persistence.
Yamamoto H, Matano T. Rev Med Virol. 2008 Sep-Oct; 18(5):293-303.

See reviews... See all...

Cited by over 100 PubMed Central articles

CTL Escape and Viral Fitness in HIV/SIV Infection. [Front Microbiol. 2011]
CTL Escape and Viral Fitness in HIV/SIV Infection.
Seki S, Matano T. Front Microbiol. 2011; 2:267. Epub 2012 Jan 4.
Immunogenic comparison of chimeric adenovirus 5/35 vector carrying optimized human immunodeficiency virus clade C genes and various promoters. [PLoS One. 2012]
Immunogenic comparison of chimeric adenovirus 5/35 vector carrying optimized human immunodeficiency virus clade C genes and various promoters.
Shoji M, Yoshizaki S, Mizuguchi H, Okuda K, Shimada M. PLoS One. 2012; 7(1):e30302. Epub 2012 Jan 19.
Vaccine design for CD8 T lymphocyte responses. [Cold Spring Harb Perspect Med. 2011]
Vaccine design for CD8 T lymphocyte responses.
Koup RA, Douek DC. Cold Spring Harb Perspect Med. 2011 Sep; 1(1):a007252.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Temporal association of cellular immune responses with the initial control of vi...
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
J Virol. 1994 Jul ;68(7):4650-5.

PubMed
Early versus delayed hormonal therapy for prostate specific antigen only recurre...
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.
J Urol. 2008 May ;179(5 Suppl):S53-9.

PubMed
Mortality in eating disorders: a descriptive study.
Mortality in eating disorders: a descriptive study.
Int J Eat Disord. 2000 Jul ;28(1):20-6.

PubMed
Development and validation of a new body-image assessment scale.
Development and validation of a new body-image assessment scale.
J Pers Assess. 1995 Apr ;64(2):258-69.

PubMed
Does Watching Smoking in Movies Promote Teenage Smoking?
Does Watching Smoking in Movies Promote Teenage Smoking?
Curr Dir Psychol Sci. 2009 Apr 15;18(2):63-67.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: